Immunotherapy Today

Immunotherapy News From Around The World

Immunotherapy

  • How the Gut Microbiome Helps the Immune System Fight Melanoma - Technology Networks
  • Stage IV melanoma survivor: An immunotherapy clinical trial saved my life - MD Anderson Cancer Center
  • Novel T Cell Therapies Yield Decade-Long Remission in Epithelial Cancer - CancerNetwork
  • Analyzing Nivolumab and Ipilimumab as HCC Therapy - Targeted Oncology
  • ELI-002 7P Elicits Robust T-Cell Responses in KRAS+ Pancreatic Cancer - CancerNetwork
  • Locoregional therapy combined with targeted therapy and immunotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis - Nature
  • Signatera Guides Bladder Cancer Treatment After Surgery - Cure Today
  • CONGRATS Trial Data of Nivolumab ± Relatlimab Highlight Clinical Value of Immunotherapy in TLS+ Soft Tissue Sarcoma - OncLive
  • Williams Cancer Institute Presents Data on Combined Pulsed Electrical Field Ablation and Intratumoral Immunotherapy at SITC 2025 - Oncodaily
  • FDA Approves Generic Dasatinib, Expanding Access to Key TKI - Targeted Oncology
  • Oncology Community Remains Hopeful and Bullish for 2026 - Targeted Oncology
  • Efficacy of a personalized combination regimen combining induction chemotherapy, immunotherapy, radiotherapy, and targeted therapy for locally advanced synchronous multiple primary lung cancer: a case report - Journal of Medical Case Reports
  • 10 ongoing Clinical Trials on Immunotherapy in Head and Neck cancer - Oncodaily
  • Clean scan compels patient to give back to MD Anderson - MD Anderson Cancer Center
  • Staffing Models and Workflow in Infusion vs Subcutaneous ICI Administration - Urology Times
  • Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma - Nature
  • Agenus Shares Q3 2025 Milestones in Immunotherapy Progress - Oncodaily
  • Research Recap: Empiric Immunotherapy for Highly Refractory Epilepsy - Newswise
  • Stéphane Champiat: The Evolving Role of Radiomics in Immunotherapy Drug Development at SITC 2025 - Oncodaily
  • Neeraj Agarwal Shares Insights on Phase 3 BCG + Immunotherapy Trials in High-Risk NMIBC - Oncodaily
ImmunoTherapyToday.com is a global news aggregation platform dedicated to disseminating information about research and scientific discoveries from the transformative Immunotherapy scientific research community, as well as legal, business and regulatory news pertaining to the field.
Affiliated with CRISPRInsider.com
Skype interview, April 15, 2018
Oriana Sousa of Marinha Grande, Portugal was diagnosed in 2012 with an aggressive form of Small Cell Ovarian Cancer, and after several years of downturn and discouragement, was unexpectedly "cured" through immunotherapy. She has been in total remission for two years. This is her story.

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
    August 9, 2018
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
    July 13, 2018
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
    July 12, 2018
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
    July 9, 2018
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
    July 3, 2018
  • JITC tumor and cancer immunotherapy papers collection
    June 29, 2018
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
    June 21, 2018
  • Immunotherapy shows promise for advanced lymphoma: study
    June 17, 2018
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
    June 15, 2018
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
    June 15, 2018
  • …to develop and commercialize hpv pre-cancer immunotherapy …
    May 31, 2018
  • Atara Biotherapeutics Expands T-Cell Immunotherapy …
    May 23, 2018
  • Inovio’s DNA Immunotherapy Demonstrates Immune Response …
    May 17, 2018
  • Immune Design Reports, Data Update for Lead Immunotherapy …
    April 29, 2018
  • …of U. S. firm providing immunotherapy for prostate cancer
    April 22, 2018
  • …numbers predict response to combination immunotherapy in …
    April 22, 2018
  • Immunotherapy shows promise in type 1 diabetes clinical trial…
    April 22, 2018

Contact

[recaptcha]

Copyright 2018 ImmunoTherapyToday.com